Two new studies involving monkeys suggest COVID-19 vaccine candidates can provide disease protection after a single injection — but it will take large-scale human trials to know for sure if they work.
. It uses a harmless virus to transfer genetic material from the coronavirus into the person being vaccinated. It's an approach the company has been using for years.
"We have now vaccinated 80,000 people with the vector in different diseases," said Paul Stoffels, chief scientific officer of Johnson & Johnson. And it's known to be safe., researchers at the National Institute of Allergy and Infectious Diseases tested another viral vector vaccine, this one developed by the University of Oxford. Some animals receive a single vaccination; some received two.
None of the vaccinated monkeys developed disease, but all of them still showed signs of active infection in their upper airways. As of July 1, about 8,000 human volunteers had participated in a study of the Oxford vaccine. If it is shown to prevent disease in humans, that of course would be a good thing. But if it doesn't prevent infection of the upper airway, it means a vaccinated person could still spread the disease.
He said only when the human trials have results will we know for sure if any of the vaccines being tested will actually work.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Experimental Johnson & Johnson vaccine protects monkeys in a single dose: studyJohnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
続きを読む »
China's potential Covid-19 vaccine to be tested in BrazilSix Covid19 vaccines are in phase 3 of human trials, before being approved for mass distribution. China's Sinopharm is one of them
続きを読む »
J&J starts human study of COVID-19 vaccine after promising monkey dataWhen exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published in the journal Nature. 'This gives
続きを読む »
Those coronavirus vaccines leading the race? Don’t ditch the masks quite yetThe first wave of coronavirus vaccines might be like a flu shot, experts say, curbing symptoms in some patients but not protecting them from COVID-19.
続きを読む »
GOP HEALS Act gives some businesses a second shot at Paycheck Protection Program loansThe GOP HEALS Act calls for additional funding for small businesses that have run out of their first infusion of Paycheck Protection Program loans. Sens. Marco Rubio, R-Fla., and Susan Collins, R-Maine, also propose earmarking cash for companies with no more than 10 employees.
続きを読む »